Gabriel Börner

A surgeons’s story. And solution.

It all started with a curious surgeon that encountered a clinical problem in abdominal wall closure and decided to do something about it. During practice surgeon Gabriel Börner often encountered complications after open abdominal surgery. 

This experience, together with a growing body of scientific evidence and research showing that a evidence-based surgical technique can reduce patient complications, planted an idea of a device that could help surgeons prevent hernias instead of repairing them.

Suturion AB was founded in 2018 by Gabriel Börner, medtech engineer Mats O. Christensson and LU Holding AB. Suturion have during the last years filed several patent applications, performed extensive market analysis and pre-clinical research. Gabriel Börner is a frequent speaker at medical congresses and travels the world presenting his scientific research and findings. During 2022 Suturion will start a clinical trial which is an important step toward the regulatory pathway for CE and FDA approval.

The Board

Göran Brorsson

Göran Brorsson

Chairman of the Board

Göran has 20+ yrs managerial experience in SME and big corporations in the Nordics, Europe, US and Asia. Göran held key leadership roles in operations, sales, manufacturing and distribution of medical device products. He has cross-cultural knowledge and background in management, global business development strategies and corporate transactions. Since 2015 he works as an independent advisor to MedTech and Life Science companies. He holds an MBA from Gothenburg University and has participated in the International Management Program at the International Management Institute, Geneva.

Anna Gisselsson

Anna Gisselsson

Board Member

Anna has an extensive experience from the life science sector, and a background in R&D, business development and internationalization. Currently Anna is an investment manager at Almi Invest. Anna has previously held positions at GE Healthcare, Medicon Village, Business Sweden and several start up and scale up companies within biotech and med tech. She hold a M.Sc. in Chemistry and a Ph.D. in Biochemistry (2003) from Lund University.

LinkedIn

Pia Renaudin

Pia Renaudin

Board Member

Pia has 25+ yrs of experience from the life science industry, focusing on sales&marketing. Since 4 yrs, Pia is the CEO for Senzime, a Swedish MedTech company. She previously held executive positions globally and regionally in Sweden and France. Pia Renaudin has managed many strategic product launches for global companies as AstraZeneca, Bristol Myers, Squibb, Gilead Sciences and Stryker. Pia has a MBA from University of Gothenburg (1992), and graduation from INSEAD Business School, France.

LinkedIn

Anette Sjögren

Anette Sjögren

Board Member

Anette has 30+ yrs of experience from medical device and pharma industry as QA, RA, QP and expertise in the fields of clinical affairs, toxicology and biocompatibility. Anette is a member of the Swedish (TK355) and the international Technical (TC210) committees since 2010. Since 16 years Anette is a consultant within PREVENTIA. Anette supports her customers with expertise and activities as giving training courses (open or company internal) and presenting at conferences, participate in projects for market clearance worldwide, perform audits and support in clinical affairs as well as regulatory affairs & quality assurance.

Christian Söderholm

Christian Söderholm

Board Member

Christian has 20+ yrs of experience as an entrepreneur and CEO. He has started and managed companies in Sweden, France, Holland, Czech Republic, Poland, Lithuania and Ukraine with operations in Scandinavia, Europe, Asia, Africa and America. His core strenght is on sales&marketing and he has created and managed sales network with representation in 76 countries. Today Christian manages the investment company Albin Invest with a focus on long term growth and commitment. Christian holds a M.Sc. in Business and Economics from Lund University.

LinkedIn

Gabriel Börner

Gabriel Börner

Board Member, Founder and CMO

Gabriel is a consultant trauma and emergency surgeon at Helsingborg hospital. He has special interest in teaching at all levels and patient safety issues. Gabriel is a PhD-student at Lund University and the research concerns abdominal wall closure.